These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36245104)

  • 1. Post-Injection Delirium/Sedation Syndrome: A Case Report and 2-Year Follow-Up.
    Podgorná G; Albrecht J; Buday J; Mareš T; Le TH; Kališová L; Anders M
    Am J Case Rep; 2022 Oct; 23():e937579. PubMed ID: 36245104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting injectable antipsychotics and the development of postinjection delirium/sedation syndrome (PDSS).
    Novakovic V; Adel T; Peselow E; Lindenmayer JP
    Clin Neuropharmacol; 2013; 36(2):59-62. PubMed ID: 23503549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine long-acting injection: a review of first experiences of post-injection delirium/sedation syndrome in routine clinical practice.
    Bushe CJ; Falk D; Anand E; Casillas M; Perrin E; Chhabra-Khanna R; Detke HC
    BMC Psychiatry; 2015 Apr; 15():65. PubMed ID: 25886006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Not Available].
    Mohammad M; Alaoui-Ismaili Z; Baandrup L; Barzanji AF
    Ugeskr Laeger; 2023 May; 185(19):. PubMed ID: 37170738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism.
    McDonnell DP; Detke HC; Bergstrom RF; Kothare P; Johnson J; Stickelmeyer M; Sanchez-Felix MV; Sorsaburu S; Mitchell MI
    BMC Psychiatry; 2010 Jun; 10():45. PubMed ID: 20537130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postinjection Delirium/Sedation Syndrome After 31st Long-Acting Olanzapine Depot Injection.
    Venkatesan V; Khanra S; Mandal K; Deepak MB
    Clin Neuropharmacol; 2019; 42(2):64-65. PubMed ID: 30747749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases.
    Detke HC; McDonnell DP; Brunner E; Zhao F; Sorsaburu S; Stefaniak VJ; Corya SA
    BMC Psychiatry; 2010 Jun; 10():43. PubMed ID: 20537128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline characteristics and hospitalizations in patients with schizophrenia receiving olanzapine long-acting injection: an interim analysis from a non-interventional, prospective observational safety study.
    Jones ME; Andrews JS; Faries DE; Landry J; Xu J; Detke HC; Chhabra-Khanna R; McDonnell DP
    BMC Psychiatry; 2015 Nov; 15():278. PubMed ID: 26567159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-injection delirium/sedation syndrome in patients treated with olanzapine pamoate: mechanism, incidence, and management.
    Luedecke D; Schöttle D; Karow A; Lambert M; Naber D
    CNS Drugs; 2015 Jan; 29(1):41-6. PubMed ID: 25424243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case series profile of olanzapine post-injection delirium/sedation syndrome.
    Seebaluck J; Downes MA; Brown J; Harris K; Isoardi KZ; Chan BS
    Br J Clin Pharmacol; 2023 Feb; 89(2):903-907. PubMed ID: 36349832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Post-injection delirium/sedation syndrome following injection of olanzapine pamoate: a new syndrome in emergency psychiatry].
    Buts K; Van Hecke J
    Tijdschr Psychiatr; 2014; 56(4):273-6. PubMed ID: 24807388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pooled analysis of injection site-related adverse events in patients with schizophrenia treated with olanzapine long-acting injection.
    Atkins S; Detke HC; McDonnell DP; Case MG; Wang S
    BMC Psychiatry; 2014 Jan; 14():7. PubMed ID: 24423017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are the long-acting intramuscular formulations of risperidone or paliperidone palmitate associated with post-injection delirium/sedation syndrome? An assessment of safety databases.
    Alphs L; Gopal S; Karcher K; Kent J; Sliwa JK; Kushner S; Nuamah I; Singh J
    Curr Drug Saf; 2011 Feb; 6(1):43-5. PubMed ID: 21047303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-Injection Delirium/Sedation Syndrome after Olanzapine Long-Acting Intramuscular Injection - Who is at Risk?
    Łukasik-Głębocka M; Sommerfeld K; Teżyk A; Panieński P; Żaba C; Zielińska-Psuja B
    Basic Clin Pharmacol Toxicol; 2015 Sep; 117(3):213-4. PubMed ID: 25703610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term safety and efficacy of olanzapine long-acting injection in patients with schizophrenia or schizoaffective disorder: a 6-year, multinational, single-arm, open-label study.
    McDonnell DP; Landry J; Detke HC
    Int Clin Psychopharmacol; 2014 Nov; 29(6):322-31. PubMed ID: 24850228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of post-injection delirium/sedation syndrome after application of olanzapine long-acting injection during one year period.
    Uzun S; Kozumplik O; Ćelić I; Pivac N; Mimica N
    Psychiatr Danub; 2017 Dec; 29(4):497-499. PubMed ID: 29197208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine pamoate for the treatment of schizophrenia--a safety evaluation.
    Samalin L; Garay R; Ameg A; Llorca PM
    Expert Opin Drug Saf; 2016; 15(3):403-11. PubMed ID: 26761429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postinjection delirium/sedation syndrome in patients with schizophrenia receiving olanzapine long-acting injection: results from a large observational study.
    Meyers KJ; Upadhyaya HP; Landry JL; Chhabra-Khanna R; Falk DM; Seetharama Rao B; Jones ME
    BJPsych Open; 2017 Jul; 3(4):186-192. PubMed ID: 28811926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting injectable antipsychotics: focus on olanzapine pamoate.
    Lindenmayer JP
    Neuropsychiatr Dis Treat; 2010 Jun; 6():261-7. PubMed ID: 20628628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Olanzapine long-acting post-injection syndrome: a case report and brief review].
    Duran-Sindreu SF; Grasa-Bello E; Corripio-Collado I; Sauras-Quetcuti RB; Keymer-Gausset A; Roldán-Bejarano A; Alonso-Solís A; Figueras-Vilalta M; Álvarez-Martínez E
    Actas Esp Psiquiatr; 2013; 41(1):60-2. PubMed ID: 23440537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.